Phase II Study of Tailored-Dose Docetaxel in Metastatic Breast Cancer.

Trial Profile

Phase II Study of Tailored-Dose Docetaxel in Metastatic Breast Cancer.

Completed
Phase of Trial: Phase II

Latest Information Update: 04 Oct 2012

At a glance

  • Drugs Docetaxel (Primary)
  • Indications Advanced breast cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Feb 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 06 Feb 2012 Actual end date (Feb 2006) added as reported by ClinicalTrials.gov.
    • 13 Oct 2009 Actual initiation date (Mar 1999) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top